Shopping Cart 0
Cart Subtotal
AED 0

Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Astellas Pharma Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Astellas Pharma Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Astellas Pharma Inc. (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company classifies its business into single operating segment: Pharmaceuticals. It manufactures prescription drugs in therapeutic areas of urology, oncology, immunology, nephrology, muscle diseases, ophthalmology, and neuroscience. The company operates in Japan, other Asian countries, the Americas, Europe, Middle East, and Africa (EMEA), and Oceania. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments

- Intelligence on Astellas Pharma Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Astellas Pharma Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Astellas Pharma Inc.: Company Overview 9

Astellas Pharma Inc.: Overview and Key Facts 9

Astellas Pharma Inc.: Overview 9

Astellas Pharma Inc.: Key Facts 9

Astellas Pharma Inc.: Key Employees 11

Astellas Pharma Inc.: Key Employee Biographies 13

Astellas Pharma Inc.: Major Products and Services 15

Astellas Pharma Inc.: Company History 16

Astellas Pharma Inc.: Management Statement 26

Astellas Pharma Inc.: Locations and Subsidiaries 29

Astellas Pharma Inc.: Key Competitors 30

Astellas Pharma Inc.: Company Analysis 31

Astellas Pharma Inc.: Business Description 31

Astellas Pharma Inc.: SWOT Analysis 32

Astellas Pharma Inc.: SWOT Overview 32

Astellas Pharma Inc.: Strengths 32

Astellas Pharma Inc.: Weaknesses 34

Astellas Pharma Inc.: Opportunities 34

Astellas Pharma Inc.: Threats 36

Astellas Pharma Inc.: Corporate Financial Deals Activity 38

Astellas Pharma Inc.: Financial Deals Overview 38

Astellas Pharma Inc.: Targets and Partners 40

Astellas Pharma Inc.: Top Deals 2014-2018YTD* 42

Astellas Pharma Inc.: Advisors 43

Astellas Pharma Inc.: Top Legal Advisors 43

Astellas Pharma Inc.: Top Financial Advisors 43

Astellas Pharma Inc.: Mergers and Acquisitions 44

Astellas Pharma Inc.: Corporate Venturing 45

Astellas Pharma Inc.: Partnership 46

Astellas Pharma Inc.: Divestments 47

Astellas Pharma Inc.: Recent Developments 48

Astellas Pharma Inc.: News and Events Summary 48

Astellas Pharma Inc.: Corporate Governance 51

Astellas Pharma Inc.: Corporate Social Responsibility 51

Astellas Pharma Inc.: Financial Performance 52

Astellas Pharma Inc.: Market Developments 52

Astellas Pharma Inc.: Red Flags/Distress Signals 53

A

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Astellas Pharma Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Astellas Pharma Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Astellas Pharma Inc. (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company classifies its business into single operating segment: Pharmaceuticals. It manufactures prescription drugs in therapeutic areas of urology, oncology, immunology, nephrology, muscle diseases, ophthalmology, and neuroscience. The company operates in Japan, other Asian countries, the Americas, Europe, Middle East, and Africa (EMEA), and Oceania. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments

- Intelligence on Astellas Pharma Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Astellas Pharma Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Astellas Pharma Inc.: Company Overview 9

Astellas Pharma Inc.: Overview and Key Facts 9

Astellas Pharma Inc.: Overview 9

Astellas Pharma Inc.: Key Facts 9

Astellas Pharma Inc.: Key Employees 11

Astellas Pharma Inc.: Key Employee Biographies 13

Astellas Pharma Inc.: Major Products and Services 15

Astellas Pharma Inc.: Company History 16

Astellas Pharma Inc.: Management Statement 26

Astellas Pharma Inc.: Locations and Subsidiaries 29

Astellas Pharma Inc.: Key Competitors 30

Astellas Pharma Inc.: Company Analysis 31

Astellas Pharma Inc.: Business Description 31

Astellas Pharma Inc.: SWOT Analysis 32

Astellas Pharma Inc.: SWOT Overview 32

Astellas Pharma Inc.: Strengths 32

Astellas Pharma Inc.: Weaknesses 34

Astellas Pharma Inc.: Opportunities 34

Astellas Pharma Inc.: Threats 36

Astellas Pharma Inc.: Corporate Financial Deals Activity 38

Astellas Pharma Inc.: Financial Deals Overview 38

Astellas Pharma Inc.: Targets and Partners 40

Astellas Pharma Inc.: Top Deals 2014-2018YTD* 42

Astellas Pharma Inc.: Advisors 43

Astellas Pharma Inc.: Top Legal Advisors 43

Astellas Pharma Inc.: Top Financial Advisors 43

Astellas Pharma Inc.: Mergers and Acquisitions 44

Astellas Pharma Inc.: Corporate Venturing 45

Astellas Pharma Inc.: Partnership 46

Astellas Pharma Inc.: Divestments 47

Astellas Pharma Inc.: Recent Developments 48

Astellas Pharma Inc.: News and Events Summary 48

Astellas Pharma Inc.: Corporate Governance 51

Astellas Pharma Inc.: Corporate Social Responsibility 51

Astellas Pharma Inc.: Financial Performance 52

Astellas Pharma Inc.: Market Developments 52

Astellas Pharma Inc.: Red Flags/Distress Signals 53

A

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS